Characteristic, n (%) | Excluded (n = 29) | Included (n = 35) | p value | |||
---|---|---|---|---|---|---|
Frailty measurements | EFS | 8 | (5–10) | 6 | (5–6) | 0.003 |
CFS | 4 | (3–5) | 3 | (2–4) | 0.004 | |
Katz | 6 | (6–6) | 6 | (6–6) | 0.41 | |
Handgrip (L) | 25.4 | (19.2–31.3) | 30.0 | (27.0–35.0) | 0.08 | |
Handgrip (R) | 26.9 | (20.2–33.2) | 30.1 | (23.3–34.7) | 0.38 | |
Chair sit/ stand | 4 | (3–5) | 4 | (3–5) | 0.84 | |
Demographic and risk factors | Age, years | 70 | ± 8 | 68 | ± 5 | 0.09 |
Female sex | 8 | (27.6) | 8 | (22.9) | 0.66 | |
BMI < 18.5 or ≥ 35 kg/m2 | 6 | (20.7) | 4 | (11.4) | 0.49 | |
Smoking history | 20 | (69.0) | 26 | (74.3) | 0.64 | |
Diabetes | 14 | (48.3) | 20 | (57.1) | 0.48 | |
Hypertension | 23 | (79.3) | 32 | (91.4) | 0.28 | |
Dyslipidemia | 24 | (82.8) | 32 | (91.4) | 0.45 | |
CVD | 10 | (34.5) | 3 | (8.6) | 0.01 | |
PVD | 6 | (20.7) | 8 | (22.9) | 0.83 | |
Renal failure | 5 | (17.2) | 3 | (8.6) | 0.45 | |
COPD | 6 | (20.7) | 5 | (14.3) | 0.53 | |
Pulmonary hypertension | 1 | (3.4) | 1 | (2.9) | 1.0 | |
Heart function | Atrial fibrillation | 7 | (24.1) | 4 | (11.4) | 0.20 |
MI ≤ 21 days | 3 | (10.3) | 1 | (2.9) | 0.32 | |
LVEF < 40% | 8 | (27.6) | 3 | (8.6) | 0.05 | |
CHF | 9 | (31.0) | 4 | (11.4) | 0.05 | |
NYHA class 3–4 | 19 | (65.5) | 24 | (68.6) | 0.80 | |
Surgery | Previous CV | 9 | (31.0) | 7 | (20.0) | 0.31 |
Previous surgery | 1 | (3.4) | 0 | (0.0) | 0.45 | |
Urgent status | 9 | (31.0) | 14 | (40.0) | 0.46 | |
HCT < 24% | 0 | (0.0) | 0 | (0.0) | - | |
Procedure | ||||||
CABG | 22 | (75.9) | 29 | (82.9) | 0.35 | |
Valve | 2 | (6.9) | 4 | (11.4) | ||
CABG + valve | 5 | (17.2) | 2 | (5.7) | ||
In-hospital outcomes | LOS | 11 | (7–12) | 5 | (5–7) | < 0.001 |
Discharge disposition | ||||||
Home | 13 | (44.8) | 35 | (100) | < 0.001 | |
Hospital | 15 | (51.7) | 0 | (0.0) | ||
Expired | 1 | (3.4) | 0 | (0.0) |